UTL-5g
UTL-5g is a novel small molecule TNF-α inhibitor investigated as a chemoprotective and radioprotective agent. Research demonstrates its efficacy in mitigating cisplatin-induced nephrotoxicity, hepatotoxicity, and hematotoxicity in murine models by modulating serum biomarkers and inflammatory cytokines.
Product Specifications
CAS Number
646530-37-2
Product Name Alternative
Inhibit, liver, Inhibitor, GBL-5g, hepatotoxicity, anti-inflammatory, 3-Isoxazolecarboxamide, N- (2,4-dichlorophenyl) -5-methyl-, acute, chemoprotective, Tumor Necrosis Factor Receptor, TNF Receptor, TNFR, TNF-α, toxicity, radioprotective, UTL 5g, UTL5g, UTL-5g
Field of Research
Cell Biology
Purity
99.83% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2 mg/mL (7.38 mM) ; DMSO:27.5 mg/mL (101.44 mM)
Smiles
Cc1cc (no1) C (=O) Nc1ccc (Cl) cc1Cl
Molecular Formula
C11H8Cl2N2O2
Molecular Weight
271.1
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61837R-FITC-TR 20 µL
Cullin 4A Recombinant Antibody, FITC Conjugated
Sign In for Pricing
View Details 
MBS5825176 Inquire
(Rac)-Neurodegenerative Disorder-Targeting Compound 1
Sign In for Pricing
View Details 